1,751
Views
51
CrossRef citations to date
0
Altmetric
Original Article

Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers

, , , , &
Pages 263-269 | Received 09 Oct 2013, Accepted 14 Jan 2014, Published online: 12 Mar 2014
 

Abstract

The aim of the present study is to design a mucoadhesive nano-carrier system which retains at the site of application and maximizes the therapeutic potential of anticancer drug as well as reduces their systemic side effects. In the present study PVA nanofibers of Docetaxel were prepared using electrospinning machine. The resulting nanofibers were characterized through various parameters such as surface morphology, drug loading, in-vitro drug release, tensile strength, mucoadhesiveness, drug permeability, degree of swelling and anticancer activities against selective cell lines to establish their therapeutics potential. On the basis of various evaluation results, we may conclude that the current approach comprising polymeric nanofibers can be successfully used for local delivery of anticancer drug.

Acknowledgement

Authors would like to thank the United Biotech Pvt Ltd, Baddi for providing gift sample of Docetaxel for the research work and ISF College of pharmacy, Moga for providing research facilities.

Declaration of Interest

The authors report no declarations of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.